Page last updated: 2024-08-24

erdosteine and Airflow Obstruction, Chronic

erdosteine has been researched along with Airflow Obstruction, Chronic in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (26.32)	29.6817
2010's	11 (57.89)	24.3611
2020's	3 (15.79)	2.80

Authors

Authors	Studies
Anzueto, A; Cazzola, M; Celli, BR; Matera, MG; Page, CP; Wedzicha, JA	1
Calverley, PM; Cazzola, M; Cicero, AF; Dal Negro, RW; Fontana, G; Page, C; Pozzi, E; Wedzicha, JA	1
Calzetta, L; Cazzola, M; Matera, MG; Page, C; Rogliani, P	2
Adir, Y; Avdeev, S; Calverley, PMA; Cordeiro, CR; Jesenak, M; Koblížek, V; Papi, A; Petkova, D; Rogliani, P; Tarraf, H; Tzanakis, N; Ulmeanu, R; Uzaslan, E	1
Calzetta, L; Cazzola, M; Hanania, NA; Matera, MG; Rogliani, P	1
Calverley, PMA; Cicero, AF; Dal Negro, RW; Fontana, G; Iversen, M; Page, C; Pozzi, E; Wedzicha, JA	1
Calzetta, L; Cazzola, M; Matera, MG; Page, C; Puxeddu, E; Rogliani, P	1
Dal Negro, RW; Turco, P; Visconti, M	1
Fagnani, S; Moretti, M	1
Dal Negro, RW; Visconti, M	1
Bertacco, S; Dal Negro, R; Micheletto, C; Tognella, S; Trevisan, F; Visconti, M	1
Moretti, M	1
Cazzola, M; Floriani, I; Page, CP	1
Dal Negro, RW; Micheletto, C; Tognella, S; Visconti, M	2
Bottrighi, P; Da Porto, R; Dallari, R; De Gugliemo, M; Dolcetti, A; Garuti, G; Grandi, P; Guffanti, E; Moretti, M; Potena, A; Roversi, P	1

Reviews

7 review(s) available for erdosteine and Airflow Obstruction, Chronic

Article	Year
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD. Respiratory research, 2023, Jul-31, Volume: 24, Issue:1 Topics: Acetylcysteine; Adrenal Cortex Hormones; Antioxidants; Expectorants; Humans; Inflammation; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Sulfhydryl Compounds	2023
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent. Drugs, 2020, Volume: 80, Issue:17 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Antioxidants; Drug Therapy, Combination; Expectorants; Humans; Lung; Oxidative Stress; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Symptom Flare Up; Thioglycolates; Thiophenes; Treatment Outcome	2020
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. COPD, 2017, Volume: 14, Issue:5 Topics: Acetylcysteine; Ambroxol; Carbocysteine; Disease Progression; Expectorants; Humans; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Thioglycolates; Thiophenes	2017
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis. Pulmonary pharmacology & therapeutics, 2018, Volume: 48 Topics: Bronchitis, Chronic; Expectorants; Hospitalization; Humans; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Thioglycolates; Thiophenes; Treatment Outcome	2018
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respiratory research, 2019, May-27, Volume: 20, Issue:1 Topics: Acetylcysteine; Antioxidants; Carbocysteine; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Thioglycolates; Thiophenes; Treatment Outcome	2019
Erdosteine: its relevance in COPD treatment. Expert opinion on drug metabolism & toxicology, 2009, Volume: 5, Issue:3 Topics: Animals; Antioxidants; Bronchitis; Clinical Trials as Topic; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Quality of Life; Severity of Illness Index; Thioglycolates; Thiophenes	2009
The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data. Pulmonary pharmacology & therapeutics, 2010, Volume: 23, Issue:2 Topics: Adult; Aged; Bronchitis, Chronic; Cough; Expectorants; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Sputum; Thioglycolates; Thiophenes; Viscosity	2010

Trials

9 trial(s) available for erdosteine and Airflow Obstruction, Chronic

Article	Year
Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation. International journal of chronic obstructive pulmonary disease, 2019, Volume: 14 Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Disease Progression; Double-Blind Method; Europe; Expectorants; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Severity of Illness Index; Thioglycolates; Thiophenes; Time Factors; Treatment Outcome	2019
Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study. The European respiratory journal, 2017, Volume: 50, Issue:4 Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Expectorants; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Severity of Illness Index; Symptom Flare Up; Thioglycolates; Thiophenes; Treatment Outcome	2017
Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial. Pulmonary pharmacology & therapeutics, 2015, Volume: 33 Topics: Administration, Oral; Adult; Aged; Albuterol; Antioxidants; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Expectorants; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes	2015
Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD. International journal of chronic obstructive pulmonary disease, 2015, Volume: 10 Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Disease Progression; Drug Administration Schedule; Expectorants; Female; Forced Expiratory Volume; Humans; Inflammation Mediators; Italy; Lung; Male; Middle Aged; Patient Discharge; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Recurrence; Single-Blind Method; Thioglycolates; Thiophenes; Time Factors; Treatment Outcome	2015
Erdosteine reduces the exercise-induced oxidative stress in patients with severe COPD: Results of a placebo-controlled trial. Pulmonary pharmacology & therapeutics, 2016, Volume: 41 Topics: Aged; Anti-Inflammatory Agents; Antioxidants; Double-Blind Method; Exercise; Exercise Test; Expectorants; Female; Humans; Inflammation Mediators; Male; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Severity of Illness Index; Thioglycolates; Thiophenes	2016
Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD. Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5 Topics: Adrenergic beta-Agonists; Aged; Albuterol; Bronchi; Drug Synergism; Expectorants; Female; Forced Expiratory Volume; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes	2008
Erdosteine affects eicosanoid production in COPD. International journal of clinical pharmacology and therapeutics, 2011, Volume: 49, Issue:1 Topics: Aged; Antioxidants; Double-Blind Method; Eicosanoids; Female; Forced Expiratory Volume; Humans; Leukotriene B4; Leukotriene E4; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes	2011
The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study. Drugs under experimental and clinical research, 2004, Volume: 30, Issue:4 Topics: Administration, Oral; Aged; Capsules; Drug Administration Schedule; Economics, Pharmaceutical; Exercise Test; Female; Humans; Italy; Male; Patient Selection; Pulmonary Disease, Chronic Obstructive; Quality of Life; Spirometry; Surveys and Questionnaires; Thioglycolates; Thiophenes; Time Factors; Treatment Outcome	2004
Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD. Pulmonary pharmacology & therapeutics, 2008, Volume: 21, Issue:2 Topics: Aged; Analysis of Variance; Antioxidants; Breath Tests; Bronchi; Cytokines; Dinoprost; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Nitric Oxide; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Smoking; Thioglycolates; Thiophenes; Time Factors; Tumor Necrosis Factor-alpha	2008

Other Studies

3 other study(ies) available for erdosteine and Airflow Obstruction, Chronic

Article	Year
Use of mucolytics in COPD: A Delphi consensus study. Respiratory medicine, 2020, Volume: 175 Topics: Acetylcysteine; Carbocysteine; Consensus; Drug Therapy, Combination; Expectorants; Female; Health Status; Humans; Internationality; Male; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires; Symptom Flare Up; Thioglycolates; Thiophenes; Treatment Outcome	2020
Erdosteine for COPD exacerbations. Drug and therapeutics bulletin, 2008, Volume: 46, Issue:10 Topics: Adult; Anti-Bacterial Agents; Drug Combinations; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Thioglycolates; Thiophenes	2008
[ Erdosteine (Mucodox), oral administration]. Journal de pharmacie de Belgique, 2011, Issue:2 Topics: Bronchial Diseases; Expectorants; Humans; Pulmonary Disease, Chronic Obstructive; Thioglycolates; Thiophenes	2011